Evidence map›Paper›PMID 32741363›Full record

ArticleNeural development2020

The SLC36 transporter Pathetic is required for neural stem cell proliferation and for brain growth under nutrition restriction.

Shiyun Feng, Evanthia Zacharioudaki, Kat Millen, Sarah J Bray

Open access · goldAbstract read
In one paragraph

Article in Neural development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. NADThe EMBO journal · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Inflammatory cytokine upd3 induces axon length-dependent synapse removal by glia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shiyun FengDepartment of Physiology Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK.
Evanthia ZacharioudakiDepartment of Physiology Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK.
Kat MillenDepartment of Physiology Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK.
Sarah J BrayDepartment of Physiology Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3DY, UK. sjb32@cam.ac.uk.ORCID 0000-0002-1642-599X
University of Cambridge · GB

Funding

Medical Research Council G0800034Medical Research Council MR/L007177/1
6 · The paper itself

Abstract

backgroundDrosophila neuroblasts (NBs) are neural stem cells whose maintenance relies on Notch activity. NBs proliferate throughout larval stages to generate a large number of adult neurons. Their proliferation is protected under conditions of nutrition restriction but the mechanisms responsible are not fully understood. As amino acid transporters (Solute Carrier transporters, SLCs), such as SLC36, have important roles in coupling nutrition inputs to growth pathways, they may have a role in this process. For example, an SLC36 family transporter Pathetic (Path) that supports body size and neural dendrite growth in Drosophila, was identified as a putative Notch target in genome-wide studies. However, its role in sustaining stem cell proliferation and maintenance has not been investigated. This study aimed to investigate the function of Path in the larval NBs and to determine whether it is involved in protecting them from nutrient deprivation.

methodsThe expression and regulation of Path in the Drosophila larval brain was analysed using a GFP knock-in allele and reporter genes containing putative Notch regulated enhancers. Path function in NB proliferation and overall brain growth was investigated under different nutrition conditions by depleting it from specific cell types in the CNS, using mitotic recombination to generate mutant clones or by directed RNA-interference.

resultsPath is expressed in both NBs and glial cells in the Drosophila CNS. In NBs, path is directly targeted by Notch signalling via Su(H) binding at an intronic enhancer, PathNRE. This enhancer is responsive to Notch regulation both in cell lines and in vivo. Loss of path in neural stem cells delayed proliferation, consistent with it having a role in NB maintenance. Expression from pathNRE was compromised in conditions of amino acid deprivation although other Notch regulated enhancers are unaffected. However, NB-expressed Path was not required for brain sparing under amino acid deprivation. Instead, it appears that Path is important in glial cells to help protect brain growth under conditions of nutrient restriction.

conclusionsWe identify a novel Notch target gene path that is required in NBs for neural stem cell proliferation, while in glia it protects brain growth under nutrition restriction.

Indexed as

Animal Nutritional Physiological PhenomenaAnimalsBrainCell ProliferationDrosophila melanogasterDrosophila ProteinsGene Expression Regulation, DevelopmentalLarvaNeural Stem CellsDrosophila Proteinspath protein, DrosophilaAmino acid transporterNeural stem cellsNeuroblastsNotch signallingNutrition restrictionPatheticSLC36

Identifiers

PMID32741363
PMCPMC7398078
OpenAlexW3042926640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.